U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H24FN3O3
Molecular Weight 397.4427
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MDMB-FUBINACA

SMILES

COC(=O)[C@@H](NC(=O)C1=NN(CC2=CC=C(F)C=C2)C3=C1C=CC=C3)C(C)(C)C

InChI

InChIKey=RFCDVEHNYDVCMU-LJQANCHMSA-N
InChI=1S/C22H24FN3O3/c1-22(2,3)19(21(28)29-4)24-20(27)18-16-7-5-6-8-17(16)26(25-18)13-14-9-11-15(23)12-10-14/h5-12,19H,13H2,1-4H3,(H,24,27)/t19-/m1/s1

HIDE SMILES / InChI

Molecular Formula C22H24FN3O3
Molecular Weight 397.4427
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:50:25 GMT 2023
Edited
by admin
on Sat Dec 16 11:50:25 GMT 2023
Record UNII
544DR70TN4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MDMB-FUBINACA
Common Name English
MDMB(N)-BZ-F
Common Name English
FUB-MDMB
Common Name English
L-VALINE, N-((1-((4-FLUOROPHENYL)METHYL)-1H-INDAZOL-3-YL)CARBONYL)-3-METHYL-, METHYL ESTER
Systematic Name English
METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE, (S)-
Systematic Name English
METHYL (S)-2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE
Systematic Name English
MDMB-BZ-F
Common Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-MDMB-FUBINACA
Created by admin on Sat Dec 16 11:50:25 GMT 2023 , Edited by admin on Sat Dec 16 11:50:25 GMT 2023
DEA NO. 7020
Created by admin on Sat Dec 16 11:50:25 GMT 2023 , Edited by admin on Sat Dec 16 11:50:25 GMT 2023
Code System Code Type Description
WIKIPEDIA
MDMB-FUBINACA
Created by admin on Sat Dec 16 11:50:25 GMT 2023 , Edited by admin on Sat Dec 16 11:50:25 GMT 2023
PRIMARY MDMB-FUBINACA (also known as MDMB(N)-Bz-F and FUB-MDMB) is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. Although there is no pharmacological information about MDMB-FUBINACA itself, its benzyl analogue (instead of 4-fluorobenzyl) has been reported to be a potent agonist for the CB1 receptor (Ki = 0.14 nM, EC50 = 2.42nM). As of October 2015 MDMB-FUBINACA is a controlled substance in Belarus, Russia, and China.
CAS
1715016-77-5
Created by admin on Sat Dec 16 11:50:25 GMT 2023 , Edited by admin on Sat Dec 16 11:50:25 GMT 2023
NON-SPECIFIC STEREOCHEMISTRY
MANUFACTURER PRODUCT INFORMATION
MDMB-FUBINACA
Created by admin on Sat Dec 16 11:50:25 GMT 2023 , Edited by admin on Sat Dec 16 11:50:25 GMT 2023
PRIMARY MDMB-FUBINACA is a derivative of AB-FUBINACA in which the terminal aminocarbonyl moiety is replaced by a methyl ester group and the isobutyl moiety is substituted with a tert-butyl group. The physiological and toxicological properties of this compound have not been determined. This product is intended for research and forensic applications.
EPA CompTox
DTXSID501010003
Created by admin on Sat Dec 16 11:50:25 GMT 2023 , Edited by admin on Sat Dec 16 11:50:25 GMT 2023
PRIMARY
CAS
1971007-93-8
Created by admin on Sat Dec 16 11:50:25 GMT 2023 , Edited by admin on Sat Dec 16 11:50:25 GMT 2023
PRIMARY
FDA UNII
544DR70TN4
Created by admin on Sat Dec 16 11:50:25 GMT 2023 , Edited by admin on Sat Dec 16 11:50:25 GMT 2023
PRIMARY
PUBCHEM
119025665
Created by admin on Sat Dec 16 11:50:25 GMT 2023 , Edited by admin on Sat Dec 16 11:50:25 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Ki
TARGET -> AGONIST
EC50
TARGET -> AGONIST
EC50
TARGET -> AGONIST
Ki
Related Record Type Details
ACTIVE MOIETY